More than 16,000 worldwide attendees will convene in Washington, DC for the premier scientific meeting in rheumatology – ACR2016. Physicians, health professionals, and industry partners from around the world will hear about groundbreaking science changing our understanding of autoimmune diseases.
Learn more about AstraZeneca’s commitment to autoimmune diseases and our research into new investigational treatments for lupus.
Page Atlas ID: 1020015.011
Date of next review: November 2017